Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 48 (1), 10-5

Role of Hepcidin in the Pathophysiology and Diagnosis of Anemia

Affiliations

Role of Hepcidin in the Pathophysiology and Diagnosis of Anemia

Guido D'Angelo. Blood Res.

Abstract

This review summarizes the central role of hepcidin in the iron homeostasis mechanism, the molecular mechanism that can alter hepcidin expression, the relationship between hepcidin and erythropoiesis, and the pathogenetic role of hepcidin in different types of anemia. In addition, the usefulness of hepcidin dosage is highlighted, including the problems associated with analytical methods currently used as well as the measures of its molecular isoforms. Considering the central role of hepcidin in iron arrangement, it is reasonable to ponder its therapeutic use mainly in cases of iron overload. Further clinical trials are required before implementation.

Keywords: Anemia; Ferroportin; Hepcidin; Hepcidin agonist therapy; Hepcidin measurement.

Conflict of interest statement

No potential conflicts of interest relevant to this article were reported.

Figures

Fig. 1
Fig. 1
Inflammation increases interleukin-6 production. The consequent increase in hepcidin blocks macrophage iron release as well as the intestinal absorption of iron, resulting in hypoferremia. Abbreviations: TF, transferrin; Fe, iron; DMT1, divalent metal transporter 1.
Fig. 2
Fig. 2
Pathophysiology of hemochromatosis and anemia of chronic disease.

Similar articles

  • The Hepcidin-Ferroportin System as a Therapeutic Target in Anemias and Iron Overload Disorders
    T Ganz et al. Hematology Am Soc Hematol Educ Program 2011, 538-42. PMID 22160086. - Review
    The review summarizes the current understanding of the role of hepcidin and ferroportin in normal iron homeostasis and its disorders. The various approaches to therapeuti …
  • Bone Marrow Iron Distribution, Hepcidin, and Ferroportin Expression in Renal Anemia
    L Bârsan et al. Hematology 20 (9), 543-52. PMID 25745821.
    Thus, in anemic epoetin naive non-dialysis CKD patients, hepcidin and ferroportin expression by erythroblast and macrophage are closely related to bone marrow iron distri …
  • The Pathophysiology and Pharmacology of Hepcidin
    P Ruchala et al. Trends Pharmacol Sci 35 (3), 155-61. PMID 24552640. - Review
    Inappropriate production of the iron-regulatory hormone hepcidin contributes to the pathogenesis of common iron disorders. Absolute or relative deficiency of hepcidin cau …
  • [Molecular Mechanisms of Iron Homeostasis]
    C Beaumont. Med Sci (Paris) 20 (1), 68-72. PMID 14770366. - Review
    Iron metabolism in mammals requires a complex and tightly regulated molecular network. The classical view of iron metabolism has been challenged over the past ten years b …
  • Hepcidin
    T Ganz. Rinsho Ketsueki 57 (10), 1913-1917. PMID 27725588.
    Hepcidin is an iron-regulating peptide hormone made in the liver. It controls the delivery of iron to blood plasma from intestinal cells absorbing iron, from erythrocyte- …
See all similar articles

Cited by 14 PubMed Central articles

See all "Cited by" articles

References

    1. Weinstein DA, Roy CN, Fleming MD, Loda MF, Wolfsdorf JI, Andrews NC. Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood. 2002;100:3776–3781. - PubMed
    1. Nicolas G, Chauvet C, Viatte L, et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest. 2002;110:1037–1044. - PMC - PubMed
    1. Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood. 2003;101:2461–2463. - PubMed
    1. Bergamaschi G, Villani L. Serum hepcidin: a novel diagnostic tool in disorders of iron metabolism. Haematologica. 2009;94:1631–1633. - PMC - PubMed
    1. Ganz T, Olbina G, Girelli D, Nemeth E, Westerman M. Immunoassay for human serum hepcidin. Blood. 2008;112:4292–4297. - PubMed
Feedback